Phase 3
Completed N=248
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
Cataract Extraction · Postoperative Pain · Inflammation
Source: ClinicalTrials.gov NCT00524264 ↗
Enrolled (actual)
248
Serious AEs
—
Results posted
Oct 2009
Primary outcomePrimary: Resolution of Post Operative Inflammation — 46.3; 25.6 % of participants with a score of 0
Summary
This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Resolution of Post Operative Inflammation |
46.3; 25.6 | — |
| SECONDARY Ocular Pain |
75.0; 41.0 | — |
| SECONDARY Mean Pupil Area |
41.8; 41.1 | — |
Eligibility Criteria
Inclusion Criteria
- Patients undergoing cataract surgery
Exclusion Criteria
- Uncontrolled ocular disease in cataract surgery eye
Data sourced from ClinicalTrials.gov (NCT00524264). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.